Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Nutritional Supplements Market 

5.1. COVID-19 Landscape: Nutritional Supplements Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Nutritional Supplements Market, By Form

8.1. Nutritional Supplements Market, by Form Type, 2023-2032

8.1.1. Powder

8.1.1.1. Market Revenue and Forecast (2020-2032)

8.1.2. Tablets

8.1.2.1. Market Revenue and Forecast (2020-2032)

8.1.3. Capsules

8.1.3.1. Market Revenue and Forecast (2020-2032)

8.1.4. Liquid

8.1.4.1. Market Revenue and Forecast (2020-2032)

8.1.5. Soft gels

8.1.5.1. Market Revenue and Forecast (2020-2032)

8.1.6. Others

8.1.6.1. Market Revenue and Forecast (2020-2032)

Chapter 9. Global Nutritional Supplements Market, By Product

9.1. Nutritional Supplements Market, by Product, 2023-2032

9.1.1. Sports Nutrition

9.1.1.1. Market Revenue and Forecast (2020-2032)

9.1.2. Dietary Supplements

9.1.2.1. Market Revenue and Forecast (2020-2032)

9.1.3. Fat Burner

9.1.3.1. Market Revenue and Forecast (2020-2032)

9.1.4. Functional Food

9.1.4.1. Market Revenue and Forecast (2020-2032)

9.1.5. Others

9.1.5.1. Market Revenue and Forecast (2020-2032)

Chapter 10. Global Nutritional Supplements Market, By Age Group 

10.1. Nutritional Supplements Market, by Age Group, 2023-2032

10.1.1. Kids

10.1.1.1. Market Revenue and Forecast (2020-2032)

10.1.2. Adults

10.1.2.1. Market Revenue and Forecast (2020-2032)

10.1.3. Geriatric

10.1.3.1. Market Revenue and Forecast (2020-2032)

Chapter 11. Global Nutritional Supplements Market, By Distribution Channel 

11.1. Nutritional Supplements Market, by Distribution Channel, 2023-2032

11.1.1. Supermarkets/Hypermarkets

11.1.1.1. Market Revenue and Forecast (2020-2032)

11.1.2. Specialty Stores

11.1.2.1. Market Revenue and Forecast (2020-2032)

11.1.3. Pharmacies

11.1.3.1. Market Revenue and Forecast (2020-2032)

11.1.4. E-commerce

11.1.4.1. Market Revenue and Forecast (2020-2032)

11.1.5. Others

11.1.5.1. Market Revenue and Forecast (2020-2032)

Chapter 12. Global Nutritional Supplements Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Forecast, by Form (2020-2032)

12.1.2. Market Revenue and Forecast, by Product (2020-2032)

12.1.3. Market Revenue and Forecast, by Age Group (2020-2032)

12.1.4. Market Revenue and Forecast, by Distribution Channel (2020-2032)

12.1.5. U.S.

12.1.5.1. Market Revenue and Forecast, by Form (2020-2032)

12.1.5.2. Market Revenue and Forecast, by Product (2020-2032)

12.1.5.3. Market Revenue and Forecast, by Age Group (2020-2032)

12.1.5.4. Market Revenue and Forecast, by Distribution Channel (2020-2032)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Forecast, by Form (2020-2032)

12.1.6.2. Market Revenue and Forecast, by Product (2020-2032)

12.1.6.3. Market Revenue and Forecast, by Age Group (2020-2032)

12.1.6.4. Market Revenue and Forecast, by Distribution Channel (2020-2032)

12.2. Europe

12.2.1. Market Revenue and Forecast, by Form (2020-2032)

12.2.2. Market Revenue and Forecast, by Product (2020-2032)

12.2.3. Market Revenue and Forecast, by Age Group (2020-2032)

12.2.4. Market Revenue and Forecast, by Distribution Channel (2020-2032)

12.2.5. UK

12.2.5.1. Market Revenue and Forecast, by Form (2020-2032)

12.2.5.2. Market Revenue and Forecast, by Product (2020-2032)

12.2.5.3. Market Revenue and Forecast, by Age Group (2020-2032)

12.2.5.4. Market Revenue and Forecast, by Distribution Channel (2020-2032)

12.2.6. Germany

12.2.6.1. Market Revenue and Forecast, by Form (2020-2032)

12.2.6.2. Market Revenue and Forecast, by Product (2020-2032)

12.2.6.3. Market Revenue and Forecast, by Age Group (2020-2032)

12.2.6.4. Market Revenue and Forecast, by Distribution Channel (2020-2032)

12.2.7. France

12.2.7.1. Market Revenue and Forecast, by Form (2020-2032)

12.2.7.2. Market Revenue and Forecast, by Product (2020-2032)

12.2.7.3. Market Revenue and Forecast, by Age Group (2020-2032)

12.2.7.4. Market Revenue and Forecast, by Distribution Channel (2020-2032)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Forecast, by Form (2020-2032)

12.2.8.2. Market Revenue and Forecast, by Product (2020-2032)

12.2.8.3. Market Revenue and Forecast, by Age Group (2020-2032)

12.2.8.4. Market Revenue and Forecast, by Distribution Channel (2020-2032)

12.3. APAC

12.3.1. Market Revenue and Forecast, by Form (2020-2032)

12.3.2. Market Revenue and Forecast, by Product (2020-2032)

12.3.3. Market Revenue and Forecast, by Age Group (2020-2032)

12.3.4. Market Revenue and Forecast, by Distribution Channel (2020-2032)

12.3.5. India

12.3.5.1. Market Revenue and Forecast, by Form (2020-2032)

12.3.5.2. Market Revenue and Forecast, by Product (2020-2032)

12.3.5.3. Market Revenue and Forecast, by Age Group (2020-2032)

12.3.5.4. Market Revenue and Forecast, by Distribution Channel (2020-2032)

12.3.6. China

12.3.6.1. Market Revenue and Forecast, by Form (2020-2032)

12.3.6.2. Market Revenue and Forecast, by Product (2020-2032)

12.3.6.3. Market Revenue and Forecast, by Age Group (2020-2032)

12.3.6.4. Market Revenue and Forecast, by Distribution Channel (2020-2032)

12.3.7. Japan

12.3.7.1. Market Revenue and Forecast, by Form (2020-2032)

12.3.7.2. Market Revenue and Forecast, by Product (2020-2032)

12.3.7.3. Market Revenue and Forecast, by Age Group (2020-2032)

12.3.7.4. Market Revenue and Forecast, by Distribution Channel (2020-2032)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Forecast, by Form (2020-2032)

12.3.8.2. Market Revenue and Forecast, by Product (2020-2032)

12.3.8.3. Market Revenue and Forecast, by Age Group (2020-2032)

12.3.8.4. Market Revenue and Forecast, by Distribution Channel (2020-2032)

12.4. MEA

12.4.1. Market Revenue and Forecast, by Form (2020-2032)

12.4.2. Market Revenue and Forecast, by Product (2020-2032)

12.4.3. Market Revenue and Forecast, by Age Group (2020-2032)

12.4.4. Market Revenue and Forecast, by Distribution Channel (2020-2032)

12.4.5. GCC

12.4.5.1. Market Revenue and Forecast, by Form (2020-2032)

12.4.5.2. Market Revenue and Forecast, by Product (2020-2032)

12.4.5.3. Market Revenue and Forecast, by Age Group (2020-2032)

12.4.5.4. Market Revenue and Forecast, by Distribution Channel (2020-2032)

12.4.6. North Africa

12.4.6.1. Market Revenue and Forecast, by Form (2020-2032)

12.4.6.2. Market Revenue and Forecast, by Product (2020-2032)

12.4.6.3. Market Revenue and Forecast, by Age Group (2020-2032)

12.4.6.4. Market Revenue and Forecast, by Distribution Channel (2020-2032)

12.4.7. South Africa

12.4.7.1. Market Revenue and Forecast, by Form (2020-2032)

12.4.7.2. Market Revenue and Forecast, by Product (2020-2032)

12.4.7.3. Market Revenue and Forecast, by Age Group (2020-2032)

12.4.7.4. Market Revenue and Forecast, by Distribution Channel (2020-2032)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Forecast, by Form (2020-2032)

12.4.8.2. Market Revenue and Forecast, by Product (2020-2032)

12.4.8.3. Market Revenue and Forecast, by Age Group (2020-2032)

12.4.8.4. Market Revenue and Forecast, by Distribution Channel (2020-2032)

12.5. Latin America

12.5.1. Market Revenue and Forecast, by Form (2020-2032)

12.5.2. Market Revenue and Forecast, by Product (2020-2032)

12.5.3. Market Revenue and Forecast, by Age Group (2020-2032)

12.5.4. Market Revenue and Forecast, by Distribution Channel (2020-2032)

12.5.5. Brazil

12.5.5.1. Market Revenue and Forecast, by Form (2020-2032)

12.5.5.2. Market Revenue and Forecast, by Product (2020-2032)

12.5.5.3. Market Revenue and Forecast, by Age Group (2020-2032)

12.5.5.4. Market Revenue and Forecast, by Distribution Channel (2020-2032)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Forecast, by Form (2020-2032)

12.5.6.2. Market Revenue and Forecast, by Product (2020-2032)

12.5.6.3. Market Revenue and Forecast, by Age Group (2020-2032)

12.5.6.4. Market Revenue and Forecast, by Distribution Channel (2020-2032)

Chapter 13. Company Profiles

13.1. Abbott Nutrition

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Amway

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Nestle

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Glanbia Plc

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Herbalife International of America

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. Archer Daniels Midland

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. GlaxoSmithKline

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Nature’s Bounty Co.

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. Arkopharma Laboratories Pharmaceutiques

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. DuPont

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

13.11. American Health, Inc.

13.11.1. Company Overview

13.11.2. Product Offerings

13.11.3. Financial Performance

13.11.4. Recent Initiatives

13.12. Pfizer, Inc.

13.12.1. Company Overview

13.12.2. Product Offerings

13.12.3. Financial Performance

13.12.4. Recent Initiatives

13.13. Stepan Company

13.13.1. Company Overview

13.13.2. Product Offerings

13.13.3. Financial Performance

13.13.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms